SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shilpa Medicare informs about proceedings of AGM

17 Sep 2024 Evaluate

Pursuant to Regulation 30 of the Listing Regulations, Shilpa Medicare has submitted the details regarding the proceedings of 37th Annual General Meeting (‘AGM’) of the Company (enclosed as Annexure) held on Tuesday, 17th September 2024 at 10.00 am and concluded at 11.11 am (including time allowed for e-voting at the AGM) through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) at the Registered office of the Company. The Insta-Poll commenced after the conclusion of AGM for 15 minutes. Summary of proceedings as required under Regulation 30, Part-A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations annexed hereto.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

413.80 -13.75 (-3.22%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×